Daiwa Securities Group Inc. Collegium Pharmaceutical, Inc Transaction History
Daiwa Securities Group Inc.
- $27.1 Billion
- Q2 2025
A detailed history of Daiwa Securities Group Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 127 shares of COLL stock, worth $4,069. This represents 0.0% of its overall portfolio holdings.
Number of Shares
127
Previous 127
-0.0%
Holding current value
$4,069
Previous $4,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding COLL
# of Institutions
242Shares Held
36.4MCall Options Held
52.5KPut Options Held
200-
Black Rock Inc. New York, NY5.79MShares$186 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3.16MShares$101 Million2.15% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$84.6 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$72 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.58MShares$50.8 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.09B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...